Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in increased expression of KIF2C mRNA | increases expression | 19031421
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of KIF2C mRNA | increases expression | 20713471
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of KIF2C mRNA | decreases expression | 12958071
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of KIF2C protein | affects expression | 20106945
|
D001374 |
Azacitidine |
[Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA | affects cotreatment|affects expression | 18720364
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of KIF2C mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of KIF2C mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KIF2C mRNA | decreases expression | 19150397 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of KIF2C mRNA | increases expression | 15003993
|
D002104 |
Cadmium |
Cadmium results in increased expression of KIF2C mRNA | increases expression | 19031421
|
C099555 |
CD 437 |
CD 437 results in decreased expression of KIF2C mRNA | decreases expression | 12958071
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of KIF2C mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of KIF2C mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of KIF2C mRNA] | decreases reaction|increases expression | 17854601
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF2C mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of KIF2C mRNA | affects expression | 17351261
|
D005031 |
Ethylenethiourea |
Ethylenethiourea results in decreased expression of KIF2C mRNA | decreases expression | 18801409
|
D005031 |
Ethylenethiourea |
Ethylenethiourea results in increased expression of KIF2C mRNA | increases expression | 18801409
|
D005472 |
Fluorouracil |
KIF2C protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
D019833 |
Genistein |
Genistein affects the expression of KIF2C mRNA | affects expression | 18847459
|
D007529 |
Isoflavones |
Isoflavones results in decreased expression of KIF2C mRNA | decreases expression | 17374662
|
D008713 |
Methimazole |
Methimazole results in decreased expression of KIF2C mRNA | decreases expression | 17403546
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of KIF2C mRNA | increases expression | 20713471
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in decreased expression of KIF2C mRNA | decreases expression | 12832660
|
D009532 |
Nickel |
Nickel results in increased expression of KIF2C mRNA | increases expression | 19031421
|
C494474 |
perchlorate |
perchlorate results in decreased expression of KIF2C mRNA | decreases expression | 17403546 18801409
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of KIF2C mRNA | decreases expression | 17403546
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of KIF2C mRNA | decreases expression | 17998272
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF2C mRNA | affects cotreatment|increases expression | 17942748
|
D013750 |
Tetrachloroethylene |
Tetrachloroethylene results in increased expression of KIF2C mRNA | increases expression | 19031421
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of KIF2C mRNA | increases expression | 19031421
|
D013792 |
Thalidomide |
[Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA | affects cotreatment|affects expression | 18720364
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of KIF2C mRNA | decreases expression | 17951470
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of KIF2C mRNA | decreases expression | 16249480
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.78 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
7.78 | 8333272 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.66 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.33 | 16166738 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.77 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.77 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Ethylenethiourea |
12.77 | 7955072 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
12.77 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.77 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.29 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.29 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.29 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.12 | 16434500 19061943 18056438 19052882 17162532 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.12 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.62 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
8.85 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
8.85 | 15955085 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.18 | 16510725 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.88 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.88 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.80 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.19 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.38 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
11.38 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.38 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.20 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.26 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
6.55 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
6.55 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.14 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
13.97 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.97 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.97 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
6.70 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.70 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
6.70 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
6.70 | 19217205 16595493 15136595 18608205 16557594 16110121 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.70 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
6.70 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
6.70 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.70 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachloroethylene |
6.70 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.70 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.31 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.38 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
12.72 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
12.72 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
12.72 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.87 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.34 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
13.34 | 10737359 16328049 11831363 16878318 16698587 18788625 17162532 20727157 19107877 16288022 19383236 10672840 18494052 3084413 16830150 20214788 18691550 19701751 20935162 17173139 16807293 18393292 18056438 18506893 20432363 16502159 16681979 17055752 18785209 20514400 17428255 17978847 20512989 18210153 19418558 17138121 16540662 16569478 19394651 19171122 20101231 19052882 18971187 19208518 20084675 17761372 20524982 19919837 18665156 16935385 19519916 19539802 18978308 21159647 19335982 3581430 20007298 19822196 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
13.34 | 16332177 16799960 17045692 18930000 17971768 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
13.34 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.34 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
13.34 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.34 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.89 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.43 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
13.43 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.43 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.43 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.43 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.13 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
7.13 | 17689850 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.93 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
23.89 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
23.89 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
23.89 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
23.89 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
23.89 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
23.89 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.31 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
14.85 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
14.85 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
14.85 | 18291259 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
5.92 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
12.36 | 18590720 15913567 7624871 19486331 12927374 18164287 16629650 15500046 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.36 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.36 | 17681005 11677210 16105132 17110522 16919318 15861022 17333356 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
5.57 | 10220858 19407337 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.87 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.37 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.37 | 9407595 |
MESH:D003092 |
Colitis |
|
Thalidomide |
8.98 | 16680017 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.98 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.67 | 17016597 15001691 16340194 16510598 17287894 17725105 17172411 17169374 18772588 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.67 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.54 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.54 | 17016601 17401013 17255274 16524972 17594712 18802399 18949393 16303861 18288408 15148649 18448328 20501625 16391804 16282729 15289873 18509181 17094418 16331619 14970324 18383874 17695437 17454858 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
3.54 | 17116718 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 14669216 17141729 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.30 | 9301478 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.02 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.72 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
3.72 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.72 | 9125849 10589399 14991402 17551590 9224671 16925845 9211117 9142499 9664655 8800419 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.03 | 16078585 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.51 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.69 | 17244072 17100760 19470301 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.38 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.67 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.67 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
5.83 | 18289764 20133375 17522070 7624871 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
5.83 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.83 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.56 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.14 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
6.14 | 8113982 16716910 8273558 15177302 9599246 11698051 7812673 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.00 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.00 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.92 | 12538720 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.31 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Ethylenethiourea |
11.66 | 7955072 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
11.66 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.66 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.83 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.78 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.78 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.78 | 16337965 17638652 15173087 16785472 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.15 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.15 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.61 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
11.61 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
11.61 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.66 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.13 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.13 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.13 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.40 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.02 | 12701121 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.94 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.61 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.61 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.09 | 16145905 |
MESH:D005910 |
Glioma |
|
Thalidomide |
6.09 | 16327979 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.05 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.17 | 15102660 15162350 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.17 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.87 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.23 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.23 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.23 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.14 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
4.43 | 18590720 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.62 | 15340226 12621046 16120746 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.67 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.93 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
4.70 | 17290160 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.00 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.29 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.58 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.58 | 18670907 18850075 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.35 | 14678291 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.54 | 16569931 16945680 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
11.04 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
11.04 | 8137927 18031379 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.20 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.03 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.03 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
14.35 | 18785209 |
MESH:D007249 |
Inflammation |
|
Nickel |
14.35 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.35 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
14.35 | 15177302 8273558 11698051 7812673 7562506 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
14.35 | 16134734 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.49 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.10 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.10 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
9.25 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.25 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.25 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.65 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
6.65 | 16985049 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.13 | 16514283 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
9.80 | 19148494 |
MESH:D007938 |
Leukemia |
|
Genistein |
9.80 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.80 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
8.96 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.96 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.05 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
6.05 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.05 | 19850784 16294345 17596541 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.93 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.97 | 17368321 19642359 16331271 16823087 19029980 16891316 12679006 19035177 16140955 17107899 15748426 17649720 16766008 17339181 17506722 16788101 17301526 17712046 16935935 17361223 19225113 19075265 17217047 17294898 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
7.90 | 10473037 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.90 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.54 | 20032147 18407596 18522880 19638242 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
6.54 | 17174718 16943688 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
4.72 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.72 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
4.72 | 15465738 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.72 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
6.45 | 17184895 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.45 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Tetrachloroethylene |
6.45 | 17267091 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.23 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.23 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
20.23 | 19254457 20434301 18648771 2422723 19294768 20583210 19427195 19255062 12112319 20118626 18754104 19256749 19499222 19551842 18977376 19850985 12771043 20501860 21278145 19996281 19426721 19833225 18644402 9163691 19812893 15885732 20452335 21071580 19638242 21167192 15175105 10737359 20101389 20492335 19690152 19090486 20137499 19642983 21047994 20405173 16942905 2862719 19073162 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Ethylenethiourea |
20.23 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
20.23 | 16603448 17045692 18383874 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.23 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.23 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.84 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
16.84 | 19126423 18093689 18775883 18164116 19009564 18282651 16267830 17854601 18544905 2563599 18079962 19004024 19539802 19519916 3124819 17942915 18253720 18308698 9362446 17174075 16842330 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
16.84 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.84 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachloroethylene |
16.84 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.99 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.68 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
14.68 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.68 | 18569708 20869020 20464547 6695378 18816296 18520028 20135361 20064080 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.68 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
14.68 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
14.68 | 11893704 16337739 21163286 20970405 16271038 7750092 17909032 1399818 6695378 15390079 10545420 9230183 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.68 | 17306315 19931552 16712894 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.68 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.68 | 11807781 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.51 | 15086387 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
9.19 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.19 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
9.19 | 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.67 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.95 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
4.95 | 12829675 17089043 16098027 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.95 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.15 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.50 | 16801185 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.80 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.83 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.83 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
7.35 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
7.35 | 15939924 15867202 16445831 19112201 15920492 17168659 15744524 19112817 15741222 19372569 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
11.65 | 17611569 19805378 17596541 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
11.65 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
11.65 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.74 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.80 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.45 | 17141266 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.46 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.27 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
14.27 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.27 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tetrachloroethylene |
14.27 | 11911487 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.27 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.39 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.05 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
21.31 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.31 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
21.31 | 16859833 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
21.31 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.71 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.71 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.12 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.83 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.25 | 16436463 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.02 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.02 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.83 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
14.04 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
14.04 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.04 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
14.04 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.04 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.69 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.51 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
11.51 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
11.51 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.51 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.43 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.02 | 18404319 12065085 18922899 8330346 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.02 | 9200351 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
12.84 | 20133375 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
12.84 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.10 | 15687053 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.17 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.17 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.07 | 17031469 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.91 | 11118676 11399792 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.39 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.39 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.39 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.39 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.39 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.39 | 17374662 17571952 17219775 16365062 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.39 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
2.39 | 16729912 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.35 | 16636307 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.02 | 12755975 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.03 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.13 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.51 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.78 | 18286688 15538739 18722050 16160472 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.84 | 16116481 16283617 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.66 | 16096327 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.75 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
20.75 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
20.75 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.75 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.75 | 8330346 8985016 18404319 12065085 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.75 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.66 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.58 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.46 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.46 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.46 | 19015929 16424979 16951190 18396642 19084572 17522103 17498489 18567086 17172411 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.46 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
3.93 | 15138204 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
4.51 | 20133375 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.36 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.92 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.49 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Ethylenethiourea |
15.49 | 11940454 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
15.49 | 15710170 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.49 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.03 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.03 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.06 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.79 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
7.79 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.79 | 16712894 11723127 17306315 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.46 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.46 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.46 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.03 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.33 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.70 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.19 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
11.19 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.29 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.79 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.73 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.16 | 17120751 |